Suven Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 08-May-2025.
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Pharmaceuticals (which has merged into Cohance Lifesciences) has told the stock exchange that the record date for its Merger / Hive-Off scheme is 8 May 2025. Investors who hold shares on or before this date in the company's register will be eligible to receive entitlements under the scheme, such as new shares of the resulting entity or any cash component. The announcement signals that the corporate restructuring has moved past the approval stage and is now entering the execution phase, where shareholder entitlements will be processed. No further financial details, ratios, or timelines beyond the record date have been disclosed in this filing.
Existing shareholders must hold their shares by 8 May 2025 to qualify for any benefits arising from the hive-off. Expect some short-term trading activity and price movement in the stock as the ex-date approaches, as non-eligible investors may exit positions.